 SOMERSET, N.J.--BUSINESS WIRE--Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that members of its executive leadership team will virtually present at the KeyBanc Life Sciences MedTech Investor Forum at 10:30 a.m. ET on March 23, 2022. A live webcast of the presentation will be accessible at and will 